Alexandria Real Estate Equities, Inc. Highlights Its Role in Advancing Blood Cancer Innovation by Enabling Life-Changing Tenant R&D, Mission-Critical Philanthropic Initiatives and Strategic Invest
Go back to Alexandria Real Estate Equities, Inc. Highlights Its Role in Advancing Blood Cancer Innovation by Enabling Life-Changing Tenant R&D, Mission-Critical Philanthropic Initiatives and Strategic Invest| ALEXANDRIA RE EQUITIES (NYSE: ARE) | Delayed: 53.34 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $53.34 | 52 Week High | $114.67 | |||
| Open | $53.34 | 52 Week Low | $70.69 | |||
| Day High | $53.34 | P/E | 35.32 | |||
| Day Low | $53.34 | EPS | $1.51 | |||
| Volume | 111 | |||||
